Delivery of compounds for the treatment of migraine through an inhalation route
Details for Australian Patent Application No. 2002310074 (hide)
International Classifications
Event Publications
19 December 2002 Complete Application Filed
Priority application(s): 60/294,203 24.05.01 US; 60/317,479 05.09.01 US
8 May 2003 Application Open to Public Inspection
Published as AU-B-2002310074
15 December 2005 Assignment before Grant
Alexza Molecular Delivery Corporation The application has been assigned to Alexza Pharmaceuticals, Inc.
4 September 2008 Application Accepted
Published as AU-B-2002310074
8 January 2009 Standard Patent Sealed
17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002310075-OPTICALLY ACTIVE COMPOUNDS CLEARING MALFORMED PROTEINS
2002310073-DELIVERY OF PHYSIOLOGICALLY ACTIVE COMPOUNDS THROUGH AN INHALATION ROUTE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser